| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
ALT5 Sigma Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.97 |
| 52 Week High | US$5.26 |
| 52 Week Low | US$0.22 |
| Beta | 2.16 |
| 11 Month Change | -11.66% |
| 3 Month Change | -48.70% |
| 1 Year Change | 143.21% |
| 33 Year Change | -67.49% |
| 5 Year Change | -42.90% |
| Change since IPO | -98.94% |
Recent News & Updates
JanOne Inc.'s (NASDAQ:JAN) Share Price Boosted 153% But Its Business Prospects Need A Lift Too
Mar 31
Recent updates
JanOne Inc.'s (NASDAQ:JAN) Share Price Boosted 153% But Its Business Prospects Need A Lift Too
Mar 31JanOne Inc. (NASDAQ:JAN) Stock Catapults 75% Though Its Price And Business Still Lag The Industry
Feb 14Shareholders May Be A Bit More Conservative With JanOne Inc.'s (NASDAQ:JAN) CEO Compensation For Now
Oct 03JanOne to acquire Soin Therapeutics
Sep 16Does JanOne (NASDAQ:JAN) Have A Healthy Balance Sheet?
Aug 17Health Check: How Prudently Does JanOne (NASDAQ:JAN) Use Debt?
Mar 21Is JanOne (NASDAQ:JAN) Using Debt In A Risky Way?
Nov 19JanOne adds Nicholas Goeders to scientific advisory board
Jun 15JanOne advances toward initiation of mid-stage peripheral artery disease trial
Jun 08JanOne under pressure on pricing $6M stock offering
Jan 29Shareholder Returns
| ALTS | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 27.1% | 2.8% | 0.2% |
| 1Y | 143.2% | 14.4% | 17.6% |
Return vs Industry: ALTS exceeded the US Pharmaceuticals industry which returned 14.4% over the past year.
Return vs Market: ALTS exceeded the US Market which returned 17.6% over the past year.
Price Volatility
| ALTS volatility | |
|---|---|
| ALTS Average Weekly Movement | 18.5% |
| Pharmaceuticals Industry Average Movement | 9.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ALTS's share price has been volatile over the past 3 months.
Volatility Over Time: ALTS's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 5 | Tony Isaac | alt5sigma.com |
ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company’s products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets.
ALT5 Sigma Corporation Fundamentals Summary
| ALTS fundamental statistics | |
|---|---|
| Market cap | US$22.99m |
| Earnings (TTM) | -US$18.58m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.2x
P/E RatioIs ALTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALTS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$18.58m |
| Earnings | -US$18.58m |
Last Reported Earnings
Mar 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.59 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 38.1% |
How did ALTS perform over the long term?
See historical performance and comparison